Maraviroc: A review of its use in hivinfection and beyond

Medicine & Life Sciences

• Maraviroc 85%
• HIV-1 41%
• Chemokine Receptors 15%
• Viral Drug Resistance 10%
• HIV-2 8%
• CXC Chemokines 8%
• CC Chemokines 8%
• CD4 Antigens 8%
• Virus Internalization 8%
• Graft vs Host Disease 7%
• United States Food and Drug Administration 6%
• Canada 6%
• Glycoproteins 5%
• Pharmacokinetics 5%
• Virus Diseases 5%
• Genotype 4%
• Viruses 4%
• Mutation 3%
• Therapeutics 3%
• Health 3%
• Infections 3%
• Pharmaceutical Preparations 2%
• Neoplasms 2%

Chemical Compounds

• Maraviroc 100%
• Chemokine Receptor CCR5 Antagonist 34%
• Antiretroviral 9%
• Glycoprotein 6%
• Mutation 5%
• Pharmacokinetics 5%
• Resistance 4%
• Drug 3%